Virax Biolabs VRAX
NASDAQ VRAX
$2.23 -0.08 (-3.65%)
At close: Sep 29, 2026 · 4:00 PM EDT

Virax Biolabs (VRAX) Receivables - Other (2021)

Updated

Virax Biolabs (VRAX) reported Receivables - Other of -$54,497 for fiscal Q4 2021 (quarter ended Mar 31, 2021).

Analysis

Virax Biolabs (VRAX) Receivables - Other (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 250.84 Bn 229.99 Bn 4.88 Bn
2 Abbott Laboratories 174.73 Bn 145.82 Bn 7.27 Bn
3 Danaher 159.85 Bn 143.67 Bn 3.61 Bn
4 Intuitive Surgical 146.79 Bn 126.35 Bn 1.96 Bn
5 Medtronic 114.54 Bn 80.41 Bn 6.34 Bn
6 Stryker 105.67 Bn 91.79 Bn 4.50 Bn
7 Boston Scientific 63.93 Bn 58.94 Bn 3.85 Bn
8 Becton Dickinson 50.12 Bn 47.27 Bn 2.32 Bn
9 Edwards Lifesciences 50.06 Bn 34.17 Bn 1.35 Bn
10 Virax Biolabs 934,336.46 -20.61 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 -54,497.00
API Access

Virax Biolabs Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=VRAX&period=max&api_key=YOUR_API_KEY